by @dministrator | Mar 1, 2021 | NevakarInjectables
By JASON J. NICHOLS, OD, MPH, PHD View the article | CLICK HERE Dr. Puri, please tell us about your company in terms of its history and direction…
by @dministrator | Oct 22, 2020 | NevakarInjectables
Bridgewater, NJ, October 22, 2020 – Nevakar Inc., a biopharmaceutical company developing multiple assets in the ophthalmic and injectable areas, announced today it received approval from the U.S. Food and Drug Administration (FDA) to market Ephedrine Sulfate Injection...
by @dministrator | Aug 24, 2020 | NevakarInjectables
December 8, 2019 – December 12, 2019
by @dministrator | Nov 28, 2019 | NevakarInjectables
Bridgewater, NJ, / Raleigh, NC, JUNE 18, 2019 – Nevakar Inc. (“Nevakar” or the “Company”), a specialty pharmaceutical company developing multiple assets in the ophthalmic and injectable areas, announced today that it recently entered into a $50...
by @dministrator | Oct 7, 2019 | NevakarInjectables
Bridgewater, NJ, OCTOBER 7, 2019 – Nevakar Inc., a specialty pharmaceutical company developing multiple assets in the ophthalmic and injectable areas, announced today that it has entered into a $17.5 million product financing agreement with an affiliate of H.I.G....
by @dministrator | Jun 18, 2019 | NevakarInjectables
Bridgewater, NJ, / Raleigh, NC, JUNE 18, 2019 – Nevakar Inc. (“Nevakar” or the “Company”), a specialty pharmaceutical company developing multiple assets in the ophthalmic and injectable areas, announced today that it recently entered into a $50...
Recent Comments